Process for producing pyridazinone compound and production intermediates thereof
US-2015376138-A1 · Dec 31, 2015 · US
US11021427B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11021427-B2 |
| Application number | US-201915733763-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 17, 2019 |
| Priority date | Apr 19, 2018 |
| Publication date | Jun 1, 2021 |
| Grant date | Jun 1, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention includes procedures for stereoselective β-acylation of carboxylic acids having a β-carbon atom. For example, stereoselective acylation procedures include the following reactions: (I)
Opening claim text (preview).
What is claimed is: 1. A method of stereoselective arylation of a β-carbon atom of a cyclopropanecarboxylic acid having a β-hydrogen atom, the cyclopropropanecarboxylic acid having either an α-substituent or having no α-substituent, comprising contacting the cyclopropanecarboxylic acid and an aryl iodide in the presence of a catalytic quantity of a Pd(II) salt, a molar equivalent or more on an Ag(I) basis of an Ag(I) salt, and a molar equivalent or more of a base, in 1,1,1,3,3,3-hexafluoroisopropanol solvent, in the presence of an single enantiomer, either (R) or (S), of an acetyl-protected aminoethyl amine (APAA) ligand of formula wherein Ac is acetyl, each R is independently selected methyl or ethyl, or the two R groups together with the nitrogen atom to which they are bonded form a 4- to 6-membered heterocyclyl ring; and wherein R 1 is an unsubstituted or substituted benzyl group, or wherein R 1 is a (C 3 -C 4 )-alkyl group; to stereoselectively provide a β-aryl-cyclopropanecarboxylic acid, wherein the arylated β-carbon atom of the β-aryl-cyclopropanecarboxylic acid product, when no α-substituent is present is of an (R) or (S) single enantiomeric configuration, respectively, and when an α-substituent is present is of an (S) or (R) single enantiomeric configuration, respectively; the aryl group introduced being disposed cis to the carboxylic acid group of the cyclopropanecarboxylic acid. 2. The method of claim 1 wherein the APAA ligand is of formula 3. The method of claim 1 wherein the Pd(II) salt is Pd(OAc) 2 . 4. The method of claim 1 wherein the carbonate base is Na 2 CO 3 , or wherein the Ag(I) salt is Ag 2 CO 3 , or both. 5. The method of claim 1 wherein the Pd(II) salt is present at about 10 mole %, the ligand is present at about 20 mole %, or both. 6. A method of stereoselective arylation of a β-carbon atom of 2-phthalimidoisobutryic acid, comprising contacting the 2-phthalimidoisobutryic acid and an aryl iodide in the presence of a catalytic quantity of a Pd(II) salt, a molar equivalent or more on an Ag(I) basis of an Ag(I) salt, and a molar equivalent or more of a base, in 1,1,1,3,3,3-hexafluoroisopropanol solvent, in the presence of an single enantiomer, either (R) or (S), of an acetyl-protected aminoethyl amine (APAA) ligand of formula wherein Ac is acetyl, each R is independently selected methyl or ethyl, or the two R groups together with the nitrogen atom to which they are bonded form a 4- to 6-membered heterocyclyl ring; and wherein R 1 is an unsubstituted or substituted benzyl group, or wherein R 1 is a (C 3 -C 4 )-alkyl group; to stereoselectively provide a β-aryl-2-phthalimidoisobutryic acid, wherein the β-aryl-2-phthalimidoisobutryic acid product is of an (R) or (S) single enantiomeric configuration, respectively. 7. The method of claim 6 wherein the APAA ligand is of formula 8. The method of claim 6 wherein the Pd(II) salt is Pd(OAc) 2 . 9. The method of claim 6 wherein the carbonate base is Na 2 CO 3 , or wherein the Ag(I) salt is Ag 2 CO 3 , or both. 10. The method of claim 6 wherein the Pd(II) salt is present at about 10 mole %, the ligand is present at about 20 mole %, or both.
by increase in the number of carbon atoms · CPC title
with oxygen atoms in positions 1 and 3, e.g. phthalimide · CPC title
by isomerisation; by change of size of the carbon skeleton · CPC title
the ester moiety containing a substituent or a structure which is considered as characteristic · CPC title
Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.